DemeRx - Press & Media

Press Release

1 year ago

DemeRx NB Inc. Advances Study for Alcohol Use Disorder Treatment

Press Release

2 weeks ago

In Waves and War: Healing Trauma Through the Science of Neuroplasticity

Upcoming Events

1 month ago

Eudēmonia Talent Portal | Deborah Mash – Dec 14, 15, 16

Press Release

1 month ago

DemeRx Awarded $1.7 Million National Institutes of Health Grant

Upcoming Events

1 month ago

Ibogaine: Past Advances and Future Perspectives – Oct 23

News beats

5 months ago

DemeRx Welcomes E. Matthew “Whiz” Buckley to Advisory Board

Press Release

5 months ago

DemeRx Appoints Biopharma Industry Veteran Vic Pirotsky to Board of Directors

Press Release

5 months ago

DemeRx Joins Medical Psychedelics Working Group to Advance Next-Generation Addiction Treatments

News beats

11 months ago

Addressing the addiction and mental health crises in the United States

News beats

1 year ago

Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential as Addiction Medicines

News beats

1 year ago

Exploring the Future of VR and Digital Therapeutics

News beats

1 year ago

The Unparalleled Power of Ibogaine in Addiction Recovery With Tom Feegel, CEO of Beond

News beats

1 year ago

Breaking the Cycle of Addiction with Ibogaine

News beats

1 year ago

Ibogaine Receives Serious Media Attention

News beats

1 year ago

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

News beats

1 year ago

Psychedelics Today Ep. 448: Deborah C. Mash, Ph.D. – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

News beats

1 year ago

Opium Addiction Market expected to rise – BioCorRx Inc, Delpor Inc, DemeRx Inc, Alar Pharmaceuticals, expected to drive market

News beats

1 year ago

Advocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study

News beats

1 year ago

Kentucky’s $42 million allocation for psychedelics research for opioid addiction

News beats

1 year ago

Rewiring an Addicted Brain | Deborah Mash – The Lindsey Elmore Show (podcast)

News beats

1 year ago

Are Psychedelics The Solution To The Opioid Crisis? – Dr. Mark Hyman

News beats

1 year ago

10 Psychedelics CEOs To Pay Attention To In 2022

News beats

1 year ago

Breaking the Cycle of Opioid Dependence with ibogaine

News beats

1 year ago

Goop podcast: The Future of Addiction Treatment

News beats

1 year ago

Ibogaine Therapies: Remodelling the Addicted Brain

News beats

1 year ago

Can a Shrub in Gabon Cure Addiction?

News beats

1 year ago

Dr. Deborah Mash on Why Ibogaine Treatment Aftercare is Key to Treating the Roots of Addiction

News beats

1 year ago

Investors & Media

DemeRx NB Inc. Advances Study for Alcohol Use Disorder Treatment

In Waves and War: Healing Trauma Through the Science of Neuroplasticity

Eudēmonia Talent Portal | Deborah Mash – Dec 14, 15, 16

DemeRx Awarded $1.7 Million National Institutes of Health Grant

Ibogaine: Past Advances and Future Perspectives – Oct 23

DemeRx Welcomes E. Matthew “Whiz” Buckley to Advisory Board

DemeRx Appoints Biopharma Industry Veteran Vic Pirotsky to Board of Directors

DemeRx Joins Medical Psychedelics Working Group to Advance Next-Generation Addiction Treatments

Addressing the addiction and mental health crises in the United States

Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential as Addiction Medicines

Exploring the Future of VR and Digital Therapeutics

The Unparalleled Power of Ibogaine in Addiction Recovery With Tom Feegel, CEO of Beond

Breaking the Cycle of Addiction with Ibogaine

Ibogaine Receives Serious Media Attention

Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction

Psychedelics Today Ep. 448: Deborah C. Mash, Ph.D. – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

Opium Addiction Market expected to rise – BioCorRx Inc, Delpor Inc, DemeRx Inc, Alar Pharmaceuticals, expected to drive market

Advocates of using psychedelic drug ibogaine to treat addiction say its risks to the heart can be mitigated in a controlled study

Kentucky’s $42 million allocation for psychedelics research for opioid addiction

Rewiring an Addicted Brain | Deborah Mash – The Lindsey Elmore Show (podcast)

Are Psychedelics The Solution To The Opioid Crisis? – Dr. Mark Hyman

10 Psychedelics CEOs To Pay Attention To In 2022

Breaking the Cycle of Opioid Dependence with ibogaine

Goop podcast: The Future of Addiction Treatment

Ibogaine Therapies: Remodelling the Addicted Brain

Can a Shrub in Gabon Cure Addiction?

Dr. Deborah Mash on Why Ibogaine Treatment Aftercare is Key to Treating the Roots of Addiction

A Medicine that May Cure Drug Addiction: ibogaine